Cognitive performance, neuroplasticity, dementia prevention, and brain aging research
889 articoli
New research links internalized stress and hopelessness to faster memory decline, pointing to a modifiable risk factor for cognitive aging.
Avlayah (tividenofusp alfa-eknm) becomes the first therapy approved to address brain damage in Hunter syndrome, a rare pediatric disorder.
NYU professor Scott Galloway and Andrew Huberman unpack what it takes for men to build meaning, health, and economic stability today.
A six-camera 3D system tracks whole-face mouse movements at sub-mm precision, unlocking new windows into neural and physiological states.
New research reveals brain movement inside the skull is mechanically driven by abdominal contractions, not heartbeat or breathing.
McGill researchers pinpointed two brain cell types altered in depression, opening doors to targeted biological treatments.
Neuroscientist Dr. Tommy Wood breaks down diet, exercise, supplementation, and cognitive stimulation strategies to protect brain health across your lifespan.
New single-nucleus RNA sequencing reveals immature neurons persist in aged human hippocampus and may actively support cognitive resilience in Alzheimer's disease.
Groundbreaking research shows neural anticipation of a virtual infection activates measurable immune responses, revealing a direct brain-immune axis.
A µ-opioid receptor superagonist shows strong analgesic potency in preclinical work while minimizing addiction, respiratory depression, and other classic opioid harms.
FDA approves an updated Spinraza regimen for spinal muscular atrophy, targeting improved CSF drug levels for better neurological outcomes.
Overexpressing Sox9 in brain support cells triggers plaque cleanup and protects cognition in Alzheimer's mouse models.
